OVARIAN NEOPLASMS
Clinical trials for OVARIAN NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new OVARIAN NEOPLASMS trials appear
Sign up with your email to follow new studies for OVARIAN NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
UK trial repurposes cancer drugs to fight rare tumors
Disease control Not yet recruitingThis UK trial is testing whether two already-approved cancer drugs, dabrafenib and trametinib, can effectively treat rare cancers or common cancers with a rare genetic change called a BRAF V600 mutation. The study will enroll about 30 adults and children with various cancers that…
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Major trial launches for Tough-to-Treat ovarian cancer
Disease control Not yet recruitingThis large, late-stage study aims to find out if a new drug called GSK5733584 works better than standard chemotherapy for women with ovarian cancer that has become resistant to platinum-based drugs. It will enroll about 450 participants to directly compare how long the cancer is …
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Spray-On chemo tested for Tough-to-Treat ovarian cancer
Disease control Not yet recruitingThis early-stage study is testing a new way to deliver chemotherapy directly into the abdomen for women with recurrent ovarian cancer that has stopped responding to standard platinum drugs. Doctors will spray a chemotherapy drug (paclitaxel) as a fine mist during a minimally inva…
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC